My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Thermo Fisher Scientific (NY:TMO)

504.82 -5.00 (-0.98%)

Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Thermo Fisher Scientific

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

26 27 Next >

Explore the top gainers and losers within the S&P500 index in today's session. ↗

January 30, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Thermo Fisher Scientific (TMO) Q4 2024 Earnings Call Transcript ↗

January 30, 2025

TMO earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

Thermo Fisher Scientific Gaps Up, Nearing A Buy Point, On Strong Earnings Beat ↗

January 30, 2025

Shares of Thermo Fisher Scientific surged Thursday after the life sciences titan beat Wall Street's fourth-quarter forecasts.

Via Investor's Business Daily

Thursday's session: gap up and gap down stock in the S&P500 index ↗

January 30, 2025

Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Thursday. Stay informed about the latest market trends.

Via Chartmill

Smart Money Is Betting Big In TMO Options ↗

January 29, 2025

Via Benzinga

Thermo Fisher Scientific Unusual Options Activity For January 21 ↗

January 21, 2025

Via Benzinga

$100 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth This Much Today ↗

January 17, 2025

Via Benzinga

How Is The Market Feeling About Thermo Fisher Scientific? ↗

November 29, 2024

Via Benzinga

Thermo Fisher Q4 Earnings Beat Estimates, Margin Expands ↗

January 30, 2025

Thermo Fisher Scientific (TMO) reports Q4 earnings of $6.10 per share, exceeding expectations. Operating income and revenue growth also increased.

Via Benzinga

Topics Earnings

9 Health Care Stocks With Whale Alerts In Today's Session ↗

January 28, 2025

Via Benzinga

Morgan Stanley Reveals Top 20 AI-Driven Stocks as Adoption Hits Critical Mass ↗

January 26, 2025

Katy Huberty, the Global Head of Research at Morgan Stanley, has spotlighted 20 stocks from companies that are likely to see significant benefits from the adoption of Artificial Intelligence (AI).

Via Benzinga

Topics Artificial Intelligence

Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery ↗

January 24, 2025

Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved investor sentiment likely.

Via Benzinga

Check Out What Whales Are Doing With TMO ↗

November 14, 2024

Via Benzinga

Market Whales and Their Recent Bets on TMO Options ↗

October 28, 2024

Via Benzinga

Earnings Scheduled For January 30, 2025 ↗

January 30, 2025

Via Benzinga

Cash Flow Focus: Thermo Fisher, Energy Transfer, and NetEase

January 24, 2025

Companies with strong cash flow and a history of impressing Wall Street analysts may make excellent prospects for 2025; TMO, ET, and NTES are three to watch.

Via MarketBeat

Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years ↗

January 01, 2025

Via Benzinga

This Omeros Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

December 23, 2024

Via Benzinga

Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.

December 20, 2024

Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.

Via News Direct

Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years ↗

December 13, 2024

Via Benzinga

Earnings Outlook For Thermo Fisher Scientific ↗

October 22, 2024

Via Benzinga

Mainz Biomed Announces Reverse Stock Split Soon After Collaborating With MedTech Giant Thermo Fisher Scientific ↗

December 03, 2024

Mainz Biomed partners with Thermo Fisher to develop advanced colorectal cancer screening tools while enhancing ColoAlert for faster, accurate results.

Via Benzinga

Mainz Biomed Inks Major Deal To Develop A Next-Generation Cancer Test

November 22, 2024

Mainz Biomed Inks Major Deal To Develop A Next-Generation Cancer Test

Via News Direct

The Oncology Bet Is Already Paying Off For Pfizer ↗

November 13, 2024

With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in October, Pfizer Inc (NYSE: PFE) reported its third quarter revenue grew 14%...

Via Benzinga

Healthcare Giant Thermo Fisher Scientific Inc. (NYSE: TMO) Inks Deal With Mainz Biomed (NASDAQ: MYNZ) To Develop And Commercialize Next Gen Colorectal Cancer Screening

November 13, 2024

Healthcare Giant Thermo Fisher Scientific Inc. (NYSE: TMO) Inks Deal With Mainz Biomed (NASDAQ: MYNZ) To Develop And Commercialize Next Gen Colorectal Cancer Screening

Via News Direct

Here's How Much $100 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth Today ↗

November 05, 2024

Via Benzinga

Tradepulse Power Inflow Alert: Thermo Fisher Scientific Inc. Climbs Over 9 Points On Session After Alert ↗

October 23, 2024

Via Benzinga

Wall Street Slumps For Third Straight Day As Investor Sentiment Fades, Dollar Strength Resumes, Boeing Disappoints: What's Driving Markets Wednesday? ↗

October 23, 2024

Wall Street is on track for its third consecutive day of losses as investors grow cautious about risky assets, awaiting more clarity on U.S. fiscal and monetary policies and scrutinizing the latest...

Via Benzinga

Thermo Fisher Scientific (TMO) Q3 2024 Earnings Call Transcript ↗

October 23, 2024

TMO earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

Thermo Fisher Scientific Sails Through Q3 With Mixed Earnings, CEO Says In Great Position To Deliver 2024 Objectives ↗

October 23, 2024

Thermo Fisher Scientific's Q3 revenue of $10.59 billion missed expectations. Adjusted EPS beat estimates but dropped year-over-year. Guidance for 2024 remains reaffirmed.

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

26 27 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.